EUVIMEDEUVIMED entdecken
Open Access

Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development

Sara Moreno-Estar iD, Pilar Cidad iD, Marycarmen Arevalo-Martinez iD, Ana M Portillo iD, Marcos Sacristan-Moraleda iD, Esperanza Alonso, Jose R Lopez-Lopez iD, M Teresa Perez-Garcia iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Sara Moreno-Estar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica y Biología Molecular y Fisiología Universidad de Valladolid Valladolid Spain. Hauptthemen laut MEDLINE: Ribosomal Protein S6 Kinases, 70-kDa, Muscle, Smooth, Vascular, Cell Movement, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular smooth muscle cell (VSMC) recruitment and activation by vessel injury cause intimal hyperplasia (IH) and restenosis. Drug‐eluting stents releasing mTOR (mechanistic target of rapamycin) blockers (sirolimus, everolimus [EV]) improve surgery outcomes but exhibit nonspecific effects and poor efficacy in diseased vessels. Drug combinations targeting the multifactorial processes leading to IH could enhance efficacy and reduce toxicity. Our previous work showed that Kv1.3 channel blockers such as 5‐(4‐phenoxybutoxy)psoralen (PAP‐1) prevented IH. Since Kv1.3 signaling works through the MEK/ERK pathway, we hypothesize that PAP‐1 and EV combination could improve antirestenotic therapies. Methods and Results The effects of PAP‐1, EV, and their combination on IH development were studied in vivo using a carotid ligation mouse model and ex vivo in organ culture of human vessels. Individually, both drugs inhibited vessel remodeling, but, surprisingly, their combination canceled these inhibitory effects. In primary human VSMCs cultures, the drug combination abolished the inhibition of cell migration but not cell proliferation, which was even potentiated. We uncovered a crosstalk between mTOR and MEK/ERK pathways in VSMCs, centered on P70S6K activation. P70S6K phosphorylation levels correlated with IH development, even reproducing the differences in EV response between diabetic and nondiabetic samples.

Conclusions

VSMC migration, rather than proliferation, mirrors PAP‐1 and EV effects on IH development in vessels. Critically, we identify VSMC P70S6K phosphorylation as a surrogate marker for IH progression. The nonmonotonic responses of P70S6K activation to pathway blockers suggest the existence of a crosstalk element functioning as an exclusive NOR logic gate providing new insights for IH prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribosomal Protein S6 Kinases, 70-kDaMuscle, Smooth, VascularCell MovementMyocytes, Smooth MuscleNeointimaCarotid Artery InjuriesAnimalsHyperplasiaHumansEverolimusDisease Models, AnimalMice, Inbred C57BLCell ProliferationCells, CulturedMiceMaleTOR Serine-Threonine KinasesSignal TransductionPhosphorylationVascular RemodelingMTOR Inhibitors

Stichwörter der Autor:innen

Kv1.3 channel blockersP70S6Keverolimusintimal hyperplasiavascular smooth muscle cell migration

Substanzen

Ribosomal Protein S6 Kinases, 70-kDaEverolimusTOR Serine-Threonine KinasesMTOR Inhibitors

Autor:innen und Institutionen

  • Departamento de Bioquímica y Biología Molecular y Fisiología Universidad de Valladolid Valladolid Spain.
  • Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), CSIC Valladolid Spain.
  • Departamento de Matemática Aplicada Universidad de Valladolid Instituto de Investigación en Matemáticas Valladolid Spain.

ORCID-Profile: Sara Moreno-Estar, Pilar Cidad, Marycarmen Arevalo-Martinez, Ana M Portillo, Marcos Sacristan-Moraleda, Jose R Lopez-Lopez, M Teresa Perez-Garcia

Zitieren

APA

Moreno-Estar, S., Cidad, P., Arevalo-Martinez, M., Portillo, A. M., Sacristan-Moraleda, M., Alonso, E., Lopez-Lopez, J. R., & Perez-Garcia, M. T. (2025). Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038358

Vancouver

Moreno-Estar S, Cidad P, Arevalo-Martinez M, Portillo AM, Sacristan-Moraleda M, Alonso E, et al. Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038358

BibTeX
@article{MorenoEstar2025,
  author = {Moreno-Estar, Sara and Cidad, Pilar and Arevalo-Martinez, Marycarmen and Portillo, Ana M and Sacristan-Moraleda, Marcos and Alonso, Esperanza and Lopez-Lopez, Jose R and Perez-Garcia, M Teresa},
  title = {Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038358}
}
Kostenlos starten →